Evidence map›Paper›PMID 32398665›Full record

ArticleNature communications2020

The transcriptional regulator ZNF398 mediates pluripotency and epithelial character downstream of TGF-beta in human PSCs.

Irene Zorzan, Marco Pellegrini, Mattia Arboit, Danny Incarnato, Mara Maldotti, Mattia Forcato, Guidantonio Malagoli Tagliazucchi, Elena Carbognin, Marco Montagner, Salvatore Oliviero and 1 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 65 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. H3K27ac Is Essential for Human Naive Pluripotency Modulated by m6A-Driven EP300 Expression.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. ZNF8 Orchestrates with Smad3 to Promote Lung Metastasis by Recruiting SMYD3 in Breast Cancer.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 4 countries.

Irene Zorzan *Department of Molecular Medicine, Medical School, University of Padua, 35121, Padua, Italy.ORCID http://orcid.org/0000-0002-9229-5293
Marco Pellegrini *Department of Molecular Medicine, Medical School, University of Padua, 35121, Padua, Italy.ORCID http://orcid.org/0000-0002-3724-6640
Mattia ArboitDepartment of Molecular Medicine, Medical School, University of Padua, 35121, Padua, Italy.
Danny IncarnatoDepartment of Life Sciences and Systems Biology and Molecular Biotechnology Center (MCB), University of Turin, 10126, Turin, Italy.
Mara MaldottiDepartment of Life Sciences and Systems Biology and Molecular Biotechnology Center (MCB), University of Turin, 10126, Turin, Italy.
Mattia ForcatoDepartment of Life Sciences, University of Modena and Reggio Emilia, 41125, Modena, Italy.
Guidantonio Malagoli TagliazucchiDepartment of Life Sciences, University of Modena and Reggio Emilia, 41125, Modena, Italy.
Elena CarbogninDepartment of Molecular Medicine, Medical School, University of Padua, 35121, Padua, Italy.ORCID http://orcid.org/0000-0001-6591-6915
Marco MontagnerDepartment of Molecular Medicine, Medical School, University of Padua, 35121, Padua, Italy.ORCID http://orcid.org/0000-0003-3080-2138
Salvatore OlivieroDepartment of Life Sciences and Systems Biology and Molecular Biotechnology Center (MCB), University of Turin, 10126, Turin, Italy. salvatore.oliviero@unito.it.ORCID http://orcid.org/0000-0002-3405-765X
Graziano MartelloDepartment of Molecular Medicine, Medical School, University of Padua, 35121, Padua, Italy. graziano.martello@unipd.it.ORCID http://orcid.org/0000-0001-5520-085X
University of Padua · ITItalian institute for Genomic Medicine · ITUniversity of Modena and Reggio Emilia · ITUniversity of Groningen · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human pluripotent stem cells (hPSCs) have the capacity to give rise to all differentiated cells of the adult. TGF-beta is used routinely for expansion of conventional hPSCs as flat epithelial colonies expressing the transcription factors POU5F1/OCT4, NANOG, SOX2. Here we report a global analysis of the transcriptional programme controlled by TGF-beta followed by an unbiased gain-of-function screening in multiple hPSC lines to identify factors mediating TGF-beta activity. We identify a quartet of transcriptional regulators promoting hPSC self-renewal including ZNF398, a human-specific mediator of pluripotency and epithelial character in hPSCs. Mechanistically, ZNF398 binds active promoters and enhancers together with SMAD3 and the histone acetyltransferase EP300, enabling transcription of TGF-beta targets. In the context of somatic cell reprogramming, inhibition of ZNF398 abolishes activation of pluripotency and epithelial genes and colony formation. Our findings have clear implications for the generation of bona fide hPSCs for regenerative medicine.

Indexed as

AnimalsCell LineCell Self RenewalCellular ReprogrammingEmbryonic Stem CellsEnhancer Elements, GeneticGain of Function MutationGene Expression RegulationGene Knockdown TechniquesHumansInduced Pluripotent Stem CellsKruppel-Like Transcription FactorsMicePromoter Regions, GeneticRNA, Small InterferingSmad3 ProteinKruppel-Like Transcription FactorsRNA, Small InterferingSmad3 ProteinSMAD3 protein, humanTransforming Growth Factor betaZNF398 protein, human

Identifiers

PMID32398665
PMCPMC7217929
OpenAlexW3025315207

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.